Professional
Added to YB: 2024-07-26
Pitch date: 2024-07-23
NTRA [bullish]
Natera, Inc.
+94.13%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
Market Cap
$28.8B
Pitch Price
$105.53
Price Target
N/A
Dividend
N/A
EV/EBITDA
-111.11
P/E
-133.35
EV/Sales
12.10
Sector
Biotechnology
Category
growth
Show full summary:
Voya Small Cap Growth Strategy Portfolio Holding: Natera, Inc.
NTRA: Prenatal genetic testing co. Strong Signatera volume driving revenue growth. Better-than-expected gross margins. 2024 rev growth guidance 23% (midpoint), likely conservative. Trimmed position due to high valuation despite strong performance. Remains top 3 holding.
Read full article (1 min)